Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bionote Inc. (377740:KRX), powered by AI.
Bionote Inc. is currently trading at ₩5,020. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bionote Inc. on Alpha Lenz.
Bionote Inc.'s P/E ratio is 9.3.
“Bionote Inc. trades at a P/E of 9.3 (undervalued) with modest ROE of 3.5%.”
Ask for details →Bionote Inc. is a leading biotechnology firm specializing in the research, development, and commercialization of diagnostic solutions. The company's primary mission is to enhance human and animal health through innovative diagnostic products that enable early and accurate detection of diseases. With a focus on both human and veterinary applications, Bionote Inc. develops advanced testing kits and instruments which are essential for clinical laboratories, medical institutions, and veterinary practices. Its diagnostic solutions cover a wide spectrum of conditions, making it pivotal in sectors such as medical research, healthcare services, and animal care industries. In the financial market, Bionote Inc. represents a vital player in the growing biotechnology industry, which is of increasing importance due to the rising emphasis on disease prevention and health management. Positioned at the forefront of the diagnostic field, Bionote Inc. contributes to the advancement of medical sciences and public health initiatives across the globe.
“Bionote Inc. trades at a P/E of 9.3 (undervalued) with modest ROE of 3.5%.”
Ask for details →